NCT07700004

Brief Summary

The aim of this study is to examine the validity and reliability of the Turkish Validity and Reliability of The King's Brief Interstitial Lung Disease Questionnaire (K-BILD) in Individuals with Interstitial Lung Involvement Secondary to Rheumatological Diseases.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for all trials

Timeline
9mo left

Started Jul 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress9%
Jul 2026May 2027

Study Start

First participant enrolled

July 5, 2026

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

July 7, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 13, 2026

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 15, 2027

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 15, 2027

Last Updated

July 13, 2026

Status Verified

July 1, 2026

Enrollment Period

6 months

First QC Date

July 7, 2026

Last Update Submit

July 7, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • King's Brief lnterstitial Lung Disease Questionnaire

    It consists of 15 items and has a seven-point Likert scale.

    10 minutes

Secondary Outcomes (3)

  • Arthritis Impact Measurement Scales (AIMS2)-Short Form

    15 minutes

  • Modified Medical Research Council (mMRC) Dyspnea Scale

    5 minutes

  • Visual Analog Scale

    3 minutes

Study Arms (1)

Group I

Interstitial Lung Involvement Secondary to Rheumatological Diseases

Behavioral: patient reported outcome measures

Interventions

King's Brief lnterstitial Lung Disease Questionnaire, Arthritis Impact Measurement Scales (AIMS2)-Short Form, Modified Medical Research Council (mMRC) Dyspnea Scale, Visual Analog Scale were evaluated.

Group I

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All patient-reported outcome measurements will be administered once, and King's Brief Interstitial Lung Disease Questionnaire will be administered twice, one week apart.

You may qualify if:

  • Being 18 years of age or older,
  • Agreeing to participate in the study.

You may not qualify if:

  • Presence of any orthopedic problem that affects functionality
  • History of any orthopedic surgery in the last year
  • Inability to speak or understand Turkish fluently
  • Presence of a psychiatric illness that affects cooperation
  • Heart failure that affects daily living activities
  • Being a cancer patient

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Usak University

Uşak, Center, 64200, Turkey (Türkiye)

Location

MeSH Terms

Interventions

Patient Reported Outcome Measures

Intervention Hierarchy (Ancestors)

Health Care SurveysSurveys and QuestionnairesData CollectionEpidemiologic MethodsInvestigative TechniquesHealth Services ResearchHealth PlanningHealth Care Economics and OrganizationsPatient Outcome AssessmentOutcome Assessment, Health CareOutcome and Process Assessment, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and EvaluationHealth Care Evaluation MechanismsPublic HealthEnvironment and Public Health

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

July 7, 2026

First Posted

July 13, 2026

Study Start

July 5, 2026

Primary Completion (Estimated)

January 15, 2027

Study Completion (Estimated)

May 15, 2027

Last Updated

July 13, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Locations